
The Art of Political Jiu-Jitsu: Project 2025 and Donald Trump
By MIKE MAGEE Funny think about that Project 2025’s “Mandate for Leadership.” Trump declared in this week’s debate, “I know nothing about it.” But in addition to the vast majority of authors and editors of the document having served in the prior Trump administration, the former President’s name is mentioned in the 887 page document…

We Should Learn to Have More Fun (or Vice-Versa)
By KIM BELLARD For several years now, my North Star for thinking about innovation has been Steven Johnson’s great quote (in his delightful Wonderland: How Play Made the Modern World): “You will find the future where people are having the most fun.” No, no, no, naysayers argue, inventing the future is serious business, and certainly…

New Entity Aims to Help Payers Improve Payment Integrity
A private equity firm announced the merger of three assets that can reduce payers’s headaches when it comes to making sure that provider-submitted claims are accurate. In turn providers can get paid quickly. The post New Entity Aims to Help Payers Improve Payment Integrity appeared first on MedCity News.

AI Can Help Better Manage Polypharmacy Patients, Study Shows
New research was published this week analyzing how AI can be used to better manage medications for senior patients who use multiple medications simultaneously. It analyzed FeelBetter’s AI platform, which pinpoints patients at high risk of deterioration and preventable hospitalization due to suboptimal medication management. The post AI Can Help Better Manage Polypharmacy Patients, Study…

On Healthcare, Trump and Harris Actually Have Some Similarities
Kamala Harris and Donald Trump have largely different healthcare policies. However, there are some areas where they have similarities, like healthcare costs. The post On Healthcare, Trump and Harris Actually Have Some Similarities appeared first on MedCity News.

Sanofi Jumps Into Radiopharmaceuticals, Paying €100M for Therapy That Could Rival a Novartis Drug
Sanofi is licensing a RadioMedix radiopharmaceutical in development for neuroendocrine tumors. The French pharmaceutical giant is responsible for global commercialization of the therapy, a potential competitor to the Novartis radiopharmaceutical Lutathera. The post Sanofi Jumps Into Radiopharmaceuticals, Paying €100M for Therapy That Could Rival a Novartis Drug appeared first on MedCity News.

KFF Health News’ ‘What the Health?’: Trump-Harris Debate Showcases Health Policy Differences
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…

The Human Touch: Why Human Transcriptionists Still Outperform AI in Healthcare
While AI continues to advance, the healthcare industry requires a level of accuracy, understanding, and confidentiality that only well-trained human transcriptionists can consistently provide. The post The Human Touch: Why Human Transcriptionists Still Outperform AI in Healthcare appeared first on MedCity News.

Our Next Generations’ Health Depends on the Oral Health of Moms
This starts with viewing specialties such as oral health, maternal health, endocrinology, and cardiology — among others — as interconnected practices, not as separate areas. It also requires combining education, innovation, and investment to truly see — and feel — positive change and interconnected care The post Our Next Generations’ Health Depends on the Oral…